Skip to main content
Premium Trial:

Request an Annual Quote

Siemens Healthineers Nabs CE Mark for Coronavirus Molecular Kit

NEW YORK ─ Siemens Healthineers said Wednesday it has received the CE mark for its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay, allowing for its use as a clinical diagnostic test in Europe.

The firm also registered the test with the Luxembourg Ministry of Health and said it plans to ship more than 1.3 million tests per month worldwide as production capacity increases in May.

The test, released as a research-use-only assay early this month, has shown 100 percent diagnostic sensitivity and 100 percent diagnostic specificity in method comparison studies when tested in Copan eSwab nasopharyngeal and oropharyngeal swabs, the company said.

Sample-to-answer time, from extraction to result, takes two to three hours, depending on the molecular system and lab resources employed, according to Siemens Healthineers.

The FTD SAR-CoV-2 Assay can analyze up to 32 patient samples per kit and be run in laboratories simultaneously with FTD Respiratory Pathogens 21 and FTD FLU/HRSV molecular syndromic testing panels, which identify a wide range of pathogens that can cause acute respiratory infections.

On Friday, the company had announced it is developing a SARS-CoV-2 serology assay to detect IgM and IgG antibodies in blood. An antibody test can help indicate whether a person has developed immunity against SARS-CoV-2 and can reveal whether individuals, including those who were asymptomatic or had never been diagnosed with the disease, had COVID-19, Siemens Healthineers noted.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.